New Laboratory Testing Firm Seeks to Shatter Old Testing Model | GenomeWeb

A Palo Alto company could be poised to potentially change the existing laboratory testing model for consumers, the San Francisco Business Times reports. 

Theranos has been offering tests based on a pin prick's worth of blood in Walgreens in the Phoenix area and one in Palo Alto, California for routine analysis such as blood cholesterol levels and diabetes, without a physician's order. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

And, Poof, It's Gone

Checking It Out

Then Again, No

Theranos Shake-Up

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.